Savior Lifetec Corporation (TPEX:4167)
Taiwan · Delayed Price · Currency is TWD 18.05
-0.15 (-0.82%)
At close: Dec 5, 2025
Savior Lifetec Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1,159 | 1,217 | 1,050 | 1,266 | 1,744 | 1,827 | Upgrade | |
Revenue Growth (YoY) | -7.92% | 15.90% | -17.02% | -27.41% | -4.57% | 38.56% | Upgrade |
Cost of Revenue | 749.73 | 870.57 | 829.33 | 1,135 | 1,436 | 1,269 | Upgrade |
Gross Profit | 409.03 | 346.76 | 220.95 | 130.99 | 307.87 | 558.64 | Upgrade |
Selling, General & Admin | 173.4 | 152.74 | 114.35 | 106.12 | 114.4 | 137.07 | Upgrade |
Research & Development | 66.72 | 75.11 | 110.96 | 119.12 | 167.27 | 179.13 | Upgrade |
Operating Expenses | 240.12 | 227.86 | 223.37 | 225.25 | 278.53 | 328.09 | Upgrade |
Operating Income | 168.92 | 118.9 | -2.42 | -94.26 | 29.34 | 230.55 | Upgrade |
Interest Expense | -5.55 | -7.48 | -9.87 | -15.69 | -17.86 | -24.22 | Upgrade |
Interest & Investment Income | 47.21 | 43.88 | 44.25 | 16.1 | 0.49 | 2.31 | Upgrade |
Earnings From Equity Investments | 0.18 | -0.18 | -0.04 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -62.53 | 60.26 | 0.36 | 53.93 | -17.19 | -14.17 | Upgrade |
Other Non Operating Income (Expenses) | 6.38 | 12.72 | 3.61 | 2.04 | 15.08 | 56.56 | Upgrade |
EBT Excluding Unusual Items | 154.61 | 228.11 | 35.9 | -37.89 | 9.86 | 251.04 | Upgrade |
Gain (Loss) on Sale of Investments | -3.97 | -46.15 | -8.78 | 2.6 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 340.52 | -8.79 | 0.42 | 65.34 | 0.1 | -0.1 | Upgrade |
Other Unusual Items | 2.12 | 6.24 | - | 6.26 | - | - | Upgrade |
Pretax Income | 493.28 | 179.4 | 27.54 | 36.31 | 9.96 | 250.94 | Upgrade |
Income Tax Expense | 0.99 | 0.99 | 0.04 | - | - | - | Upgrade |
Earnings From Continuing Operations | 492.29 | 178.41 | 27.5 | 36.31 | 9.96 | 250.94 | Upgrade |
Minority Interest in Earnings | 3.47 | 3.97 | 2.53 | 0.08 | - | - | Upgrade |
Net Income | 495.76 | 182.38 | 30.03 | 36.39 | 9.96 | 250.94 | Upgrade |
Net Income to Common | 495.76 | 182.38 | 30.03 | 36.39 | 9.96 | 250.94 | Upgrade |
Net Income Growth | 175.67% | 507.33% | -17.47% | 265.48% | -96.03% | - | Upgrade |
Shares Outstanding (Basic) | 315 | 317 | 317 | 317 | 317 | 300 | Upgrade |
Shares Outstanding (Diluted) | 316 | 318 | 339 | 317 | 318 | 336 | Upgrade |
Shares Change (YoY) | -6.78% | -6.05% | 6.79% | -0.15% | -5.41% | 23.76% | Upgrade |
EPS (Basic) | 1.58 | 0.57 | 0.09 | 0.11 | 0.03 | 0.84 | Upgrade |
EPS (Diluted) | 1.57 | 0.57 | 0.09 | 0.11 | 0.03 | 0.76 | Upgrade |
EPS Growth | 193.30% | 509.18% | -14.94% | 266.67% | -96.07% | - | Upgrade |
Free Cash Flow | 83.13 | 400.88 | 371.03 | 548.64 | -259.32 | -123.54 | Upgrade |
Free Cash Flow Per Share | 0.26 | 1.26 | 1.10 | 1.73 | -0.82 | -0.37 | Upgrade |
Dividend Per Share | 0.400 | 0.400 | 0.085 | 0.103 | - | 0.126 | Upgrade |
Dividend Growth | 370.03% | 370.03% | -17.54% | - | - | - | Upgrade |
Gross Margin | 35.30% | 28.48% | 21.04% | 10.35% | 17.66% | 30.57% | Upgrade |
Operating Margin | 14.58% | 9.77% | -0.23% | -7.45% | 1.68% | 12.62% | Upgrade |
Profit Margin | 42.78% | 14.98% | 2.86% | 2.88% | 0.57% | 13.73% | Upgrade |
Free Cash Flow Margin | 7.17% | 32.93% | 35.33% | 43.34% | -14.87% | -6.76% | Upgrade |
EBITDA | 255.04 | 230.97 | 164.9 | 100.16 | 251.86 | 436.6 | Upgrade |
EBITDA Margin | 22.01% | 18.97% | 15.70% | 7.91% | 14.44% | 23.89% | Upgrade |
D&A For EBITDA | 86.12 | 112.07 | 167.32 | 194.42 | 222.52 | 206.05 | Upgrade |
EBIT | 168.92 | 118.9 | -2.42 | -94.26 | 29.34 | 230.55 | Upgrade |
EBIT Margin | 14.58% | 9.77% | -0.23% | -7.45% | 1.68% | 12.62% | Upgrade |
Effective Tax Rate | 0.20% | 0.55% | 0.15% | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.